Skip to main content
Medical information Clinical review pending

Infection Testing

Chlamydia Trachomatis Bacterial Load Test

Detects the amount of Chlamydia trachomatis bacteria in the body using a sensitive PCR method. Essential for diagnosing Chlamydia infections and guiding treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Urethral swab, Cervical swab, Urine sample, or Vaginal swab. Confirm the required specimen type with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
Patients are required to sign a consent document. Bring any relevant clinical history to your appointment. Specific preparation instructions may vary; confirm with the laboratory.
Test priceKSh 16,320

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chlamydia Trachomatis Bacterial Load Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms of Chlamydia (e.g., unusual discharge, painful urination, pelvic pain)
  • ✓Screening for sexually active individuals, especially those with risk factors
  • ✓Partner notification and testing
  • ✓Confirmation of infection after a positive screening test
  • ✓Monitoring treatment response
  • ✓Investigation of infertility or pelvic inflammatory disease
02

In plain language

What this test helps you understand

This test helps diagnose Chlamydia trachomatis infections, determine the severity (bacterial load), guide treatment decisions, and monitor treatment effectiveness. It is important for preventing complications associated with untreated Chlamydia.
The Chlamydia Trachomatis Bacterial Load Test is a diagnostic tool used to detect the presence and quantity of the Chlamydia trachomatis bacteria. Chlamydia is a common sexually transmitted infection (STI) that can cause serious health problems if not treated promptly. This test helps identify the infection and determine its severity.

This test measures the bacterial load using Real-Time PCR, a highly sensitive and specific method. Understanding the bacterial load can assist healthcare providers in choosing the most effective treatment and monitoring its success.

Early detection through testing is crucial for preventing complications like pelvic inflammatory disease, infertility, and ectopic pregnancy. It also helps prevent the spread of the infection to others.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationPatients are required to sign a consent document. Bring any relevant clinical history to your appointment. Specific preparation instructions may vary; confirm with the laboratory.
SampleUrethral swab, Cervical swab, Urine sample, or Vaginal swab. Confirm the required specimen type with the laboratory before booking.
MethodologyReal-Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects Chlamydia trachomatis bacteria. It does not detect other STIs. Results should be interpreted in the context of clinical presentation and other relevant tests. Confirm with the laboratory for specific limitations.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Chlamydia is a common sexually transmitted infection (STI) caused by the bacterium Chlamydia trachomatis. It often has no symptoms but can lead to serious health problems if untreated.
Measuring the bacterial load helps determine the severity of the infection and can guide treatment decisions. It may also be used to monitor how well treatment is working.
Samples can be collected via urethral swab, cervical swab, urine sample, or vaginal swab. The specific type required will be determined by your healthcare provider or the laboratory.
The Real-Time PCR method used for this test is highly sensitive and specific, providing accurate results for detecting Chlamydia trachomatis.
Your doctor will interpret the results in the context of your health history and symptoms. If the test is positive, they will discuss appropriate treatment options with you.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp